Sphingosine kinase 1 is overexpressed and promotes proliferation in human thyroid cancer

Molecular Endocrinology

Volumn 25, Issue 11, 2011, Pages 1858-1866

  Guan, Hongyu ^a   Liu, Liehua ^a   Cai, Junchao ^a   Liu, Juan ^a   Ye, Caisheng ^b   Li, Mengfeng ^a   Li, Yanbing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLINE; GLYCOGEN SYNTHASE KINASE 3BETA; LYMPHOID ENHANCER FACTOR 1; PROTEIN KINASE B; SPHINGOSINE KINASE 1; T CELL FACTOR PROTEIN;

ADULT; ARTICLE; CANCER CELL; CANCER TISSUE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; RNA INTERFERENCE; THYROID CANCER; UPREGULATION; WESTERN BLOTTING;

BETA CATENIN; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOHISTOCHEMISTRY; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; THYROID NEOPLASMS;

EID: 80054976661     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1048     Document Type: Article

References (41)

1. Spiegel S, Milstien S 2007 Functions of the multifaceted family of sphingosine kinases and some close relatives. J Biol Chem 282: 2125-2129
2. Gangoiti P, Camacho L, Arana L, Ouro A, Granado MH, Brizuela L, Casas J, Fabrias G, Abad JL, Delgado A, Gomez-Munoz A 2010 Control of metabolism and signaling of simple bioactive sphingo-lipids: implications in disease. Prog Lipid Res 49:316-334
3. Xia P, Gamble JR, Rye KA, Wang L, Hii CS, Cockerill P, Khew-Goodall Y, Bert AG, Barter PJ, Vadas MA 1998 Tumor necrosis factor-a induces adhesion molecule expression through the sphingosine kinase pathway. Proc Natl Acad Sci USA 95:14196-14201
4. Spiegel S, Milstien S 2003 Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4:397-407
5. Choi JW, Lee CW, Chun J 2008 Biological roles of lysophospho-lipid receptors revealed by genetic null mice: an update. Biochim Biophys Acta 1781:531-539
6. Meyer Zu Heringdorf D 2004 Lysophospholipid receptor-dependent and -independent calcium signaling. J Cell Biochem 92:937-948
7. Chalfant CE, Spiegel S 2005 Sphingosine 1-phosphateandceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci 118:4605-4612
8. Xia P, Gamble JR, Wang L, Pitson SM, Moretti PA, Wattenberg BW, D'Andrea RJ, Vadas MA 2000 An oncogenic role of sphingosine kinase. Curr Biol 10:1527-1530
9. Shirai K, Kaneshirao T, Wada M, Furuya H, Bielawski J, Hannun YA, Obeid L, Ogretmen B, Kawamori T 2011 A role of sphingosine kinase 1 in head, neck carcinogenesis. Cancer Prev Res 4:454-462
10. Malavaud B, Pchejetski D, Mazerolles C, de Paiva GR, Calvet C, Doumerc N, Pitson S, Rischmann P, Cuvillier O 2010 Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens. Eur J Cancer 46:3417-3424
11. Liu G, Zheng H, Zhang Z, Wu Z, Xiong H, Li J, Song L 2010 Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy. BMC Cancer 10:495
12. Li W, Yu CP, Xia JT, Zhang L, Weng GX, Zheng HQ, Kong QL, Hu LJ, Zeng MS, Zeng YX, Li M, Li J, Song LB 2009 Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 15:1393-1399
13. Li J, Guan HY, Gong LY, Song LB, Zhang N, Wu J, Yuan J, Zheng YJ, Huang ZS, Li M 2008 Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival. Clin Cancer Res 14:6996-7003
14. Bayerl MG, Bruggeman RD, Conroy EJ, Hengst JA, King TS, Jimenez M, Claxton DF, Yun JK 2008 Sphingosine kinase 1 protein and mRNA are overexpressed in non-Hodgkin lymphomas and are attractive targets for novel pharmacological interventions. Leuk Lymphoma 49:948-954
15. Kapitonov D, Allegood JC, Mitchell C, Hait NC, Almenara JA, Adams JK, Zipkin RE, Dent P, Kordula T, Milstien S, Spiegel S 2009 Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts. Cancer Res 69:6915-6923
16. Dayon A, Brizuela L, Martin C, Mazerolles C, Pirot N, Doumerc N, Nogueira L, Golzio M, Teissie J, Serre G, Rischmann P, Malavaud B, Cuvillier O 2009 Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival. PLoS One 4:e8048
17. Pchejetski D, Golzio M, Bonhoure E, Calvet C, Doumerc N, Garcia V, Mazerolles C, Rischmann P, Teissie J, Malavaud B, Cuvillier O 2005 Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res 65:11667-11675
18. Bergelin N, Blom T, Heikkila J, Lof C, Alam C, Balthasar S, Slotte JP, Hinkkanen A, Tornquist K 2009 Sphingosine kinase as an oncogene: autocrine sphingosine 1-phosphate modulates ML-1 thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-a and ERK1/2. Endocrinology. 150:2055-2063
19. Jin T, George Fantus I, Sun J 2008 Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of /3-catenin. Cell Signal 20:1697-1704
20. Mayer K, Hieronymus T, Castrop J, Clevers H, Ballhausen WG 1997 Ectopic activation of lymphoid high mobility group-box transcription factor TCF-1 and overexpression in colorectal cancer cells. Int J Cancer 72:625-630
21. Hagen T, Vidal-Puig A 2002 Characterisation of the phosphorylation of /3-catenin at the GSK-3 priming site Ser45. Biochem Biophys Res Commun 294:324-328
22. Cross DA, Alessi DR, Vandenheede JR, McDowell HE, Hundal HS, Cohen P 1994 The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J 303: 21-26
23. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA 1995 Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789
24. Radeff-Huang J, Seasholtz TM, Chang JW, Smith JM, Walsh CT, Brown JH 2007 Tumor necrosis factor-a-stimulated cell proliferation is mediated through sphingosine kinase-dependent Akt activation and cyclin D expression. J Biol Chem 282:863-870
25. Lynn AAA, King SA, LiVolsi VA 1997 Utility of proliferation markers Ki-67 and proliferating cell nuclear antigen (PCNA) in the evaluation of uterine papillary serous carcinomas. Int J Surg Pathol 4:213-218
26. Lim JH, Park JW, Chun YS 2006 Human arrest defective 1 acety-lates and activates /3-catenin, promoting lung cancer cell proliferation. Cancer Res 66:10677-10682
27. Guo RJ, Huang E, Ezaki T, Patel N, Sinclair K, Wu J, Klein P, Suh ER, Lynch JP 2004 Cdx1 inhibits human colon cancer cell proliferation by reducing /3-catenin /T-cell factor transcriptional activity. J Biol Chem 279:36865-36875
28. Loveridge C, Tonelli F, Leclercq T, Lim KG, Long JS, Berdyshev E, Tate RJ, Natarajan V, Pitson SM, Pyne NJ, Pyne S 2010 The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophe-nyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells. J Biol Chem 285:38841-38852
29. Paugh BS, Bryan L, Paugh SW, Wilczynska KM, Alvarez SM, Singh SK, Kapitonov D, Rokita H, Wright S, Griswold-Prenner I, Milstien S, Spiegel S, Kordula T 2009 Interleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cells. J Biol Chem 284: 3408-3417
30. Anelli V, Gault CR, Cheng AB, Obeid LM 2008 Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2. J Biol Chem 283:3365-3675
31. Dayon A, Brizuela L, Martin C, Mazerolles C, Pirot N, Doumerc N, Nogueira L, Golzio M, Teissie J, Serre G, Rischmann P, Malavaud B, Cuvillier O 2009 Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival. PLoS One 4:e8048
32. Song L, Xiong H, Li J, Liao W, Wang L, Wu J, Li M 2011 Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-«B pathway in human non-small cell lung cancer. Clin Cancer Res 17:1839-1849
33. Guan H, Song L, Cai J, Huang Y, Wu J, Yuan J, Li J, Li M 2011 Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells. PLoS One 6:e19946
34. Xing M 2010 Genetic alterations in the phosphatidylinositol-3 ki-nase/Akt pathway in thyroid cancer. Thyroid 20:697-706
35. Ringel MD, Hayre N, Saito J, Saunier B, Schuppert F, Burch H, Bernet V, Burman KD, Kohn LD, Saji M 2001 Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res 61:6105-6111
36. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J 1994 Phosphatidyl-inositol-3-OH kinase as a direct target of Ras. Nature 370:527-532
37. Mandal M, Kim S, Younes MN, Jasser SA, El-Naggar AK, Mills GB, Myers JN 2005 The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells. Br J Cancer 92:1899-1905
38. Liu R, Liu D, Trink E, Bojdani E, Ning G, Xing M 2011 The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that Can activate the PI3K/Akt pathway. J Clin Endocrinol Metab 96:E577-E585
39. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM, DeCaprio JA, Weinberg RA 2002 Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 22:2111-2123
40. Guan H, Zhang H, Cai J, Wu J, Yuan J, Li J, Huang Z, Li M 2011 IKBKE is over-expressed in glioma and contributes to resistance of glioma cells to apoptosis via activating NF-kB. J Pathol 223:436-445
41. Li J, Zhang H, Wu J, Guan H, Yuan J, Huang Z, Li M 2010 Prognostic significance of integrin-linked kinase1 overexpression in astrocytoma. Int J Cancer 126:1436-1444